Medicare’s modifier 25 cut still punishes same-day procedures
CMS trimmed its original proposal, but the final 2027 Medicare Physician Fee Schedule still leaves clinicians with a 20% payment reduction when an office evaluation and management visit and a 0-day global minor procedure occur on the same day. The practical effect is straightforward: physicians who resolve a problem during one encounter instead of sending a patient back for a second visit will still be paid less for doing so. For busy outpatient practices, especially independent groups already balancing higher staffing and supply costs, the policy feels less like a technical adjustment than a direct penalty on efficiency.
The cut applies starting Jan. 1, 2027, and it arrives alongside a separate 2.31% reduction in the conversion factor for most clinicians once the temporary 2.5% payment patch expires at year’s end. Two payment hits landing together matter because they strike the same practices that absorb the most administrative work when care is compressed into a single appointment. In the real world, same-day evaluation and treatment often prevents unnecessary travel, avoids duplicate copays, and accelerates diagnosis.
Same-day care consumes more work, not less
CMS justifies the policy by arguing that some practice expenses are duplicated when an evaluation and a minor procedure occur together. That logic is difficult to reconcile with what happens in a functioning clinic. The patient still has to be roomed, consented, examined, and prepared. If a biopsy, lesion removal, or other minor procedure is performed on the spot, the staff must also flip the room, gather sterile instruments, and complete the procedure workflow without warning.
An unscheduled procedure does not shorten the day. It complicates it.
For physicians, the workload is not abstract. A same-day biopsy or minor intervention often comes after a clinical decision made during the visit itself, not after a tidy scheduling process. The encounter requires judgment, documentation, procedural preparation, and often coordination with pathology. In specialties such as dermatology, surgery, and primary care, the additional work is inseparable from the promise of timely care. Reducing payment for that sequence creates a perverse incentive to separate care that could safely be handled at once.
Patients pay for the delay with time, travel, and diagnosis
The payment cut may be framed as a Medicare payment refinement, but the bedside consequence is a delay in care. Patients, particularly older adults, are often dependent on family members for transportation or must travel long distances from rural communities to reach the office. When the clinician evaluates the lesion, mass, or other concern and performs the minor procedure immediately, the patient leaves with one copay, one trip, and a faster path to results.
A second visit changes that equation. It means another day away from home, another transportation burden, another copay, and a longer wait for pathology or definitive management. In pathology-driven care, time matters because diagnosis begins to crystallize only after tissue is obtained and reviewed. Pushing that procedure to another day may improve reimbursement arithmetic, but it does so by exporting cost and inconvenience to the patient while also stretching the timeline for diagnosis.
The policy creates a clean financial incentive to split care
The new rule applies when the same physician, or a same-specialty colleague in the same group, bills a 0-day global procedure with an E/M visit. Under that structure, a clinician who completes both services in one encounter receives less payment than one who separates the work into two encounters. The incentive is hard to ignore. If reimbursement rewards fragmentation, some practices will feel pressure to schedule a return visit even when immediate treatment is clinically sensible.
That is a dangerous way to design payment policy. Medicare may save money on a line-item basis if one encounter becomes two billing events, but the broader system absorbs the downstream expense. Two visits mean more office utilization, more administrative processing, and more patient time lost to avoidable logistics. When the goal is value, paying less for efficient same-day care sends the wrong signal.
Practices need documentation discipline before the rule takes effect
Even with the final policy set, practices are not powerless. Audit work should begin now, because the modifier 25 claim will need to stand on clearly documented grounds whenever a truly separate E/M service accompanies a procedure. The clinical note has to show why the evaluation was separately identifiable and medically necessary. Vague charting will not protect revenue once the reduction goes live.
Practice leaders should also review internal workflows around minor procedures. If same-day care is common in the clinic, coding teams will need a clean process for identifying which encounters qualify and which do not. The documentation burden may sound mundane, but it becomes the front line of reimbursement defense once pay cuts are attached to one of the most routine decisions in outpatient medicine: whether to treat now or ask the patient to return later.
Congress still has a narrow window to intervene
Opposition to the policy is already organized. The AMA and 149 other national and state medical societies have mobilized around a one-year delay of the modifier 25 cut, while also pressing for extension of the 2.5% conversion factor adjustment in the year-end spending package. The legislative calendar matters because the lame-duck session is the last realistic chance to prevent the cut from becoming operational on Jan. 1.
Physicians who care about access should not let the issue fade into the usual end-of-year budget churn. Same-day care is not a luxury feature of outpatient medicine; it is how clinics reduce patient burden, speed diagnosis, and use limited appointment slots efficiently. A 20% cut does not solve a duplication problem. It punishes clinicians for choosing the most efficient path and leaves patients to pay the price in time, travel, and delayed answers.